PeopleBio, Inc.
KOSDAQ-listed IVD company selling AlzOn and AlzOn+ blood-based oligomeric beta-amyloid tests for Alzheimer's risk assessment.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2002 and listed on KOSDAQ in 2020, PeopleBio is an in-vitro diagnostics medical device company. Using its MDS technology to quantitatively measure oligomeric beta-amyloid (OAβ) in blood plasma for Alzheimer's disease risk assessment, it sells the domestic AlzOn test and the export AlzOn+ test. AlzOn received Korean MFDS Class 2 medical device approval in April 2018 and new health technology recognition in December 2021, while AlzOn+ obtained CE marking in November 2020, and the company has signed exclusive 5-10 year supply agreements covering Hungary, Malaysia, Thailand, China, Australia, and the Netherlands.
Products & technology
- AlzOnblood plasma oligomeric beta-amyloid (OAβ) quantitative test for Alzheimer's risk assessment (domestic)
- AlzOn+blood plasma oligomeric beta-amyloid (OAβ) quantitative test for Alzheimer's risk assessment (export)
Regulatory approvals
data.go.kr4 Korean MFDS device approvals · 2017–2023
- MFDSChemiluminescence assay(CLIA) analyzer2023-02-03Product approval · Class 1체외 제신 23-139 호
- MFDSIVD reagents for general immune test2018-04-23Product approval · Class 2체외 제허 18-289 호
- MFDSIVD reagents for general immune test2017-11-21Product approval · Class 2체외 제인 17-4891 호
- MFDSIVD reagents for general immune testRevoked2017-05-10Product approval · Class 2체외 제인 17-4332 호
R&D and key agreements
Source: DART corporate disclosureOAβ 검사제품 임상시험 · 알츠하이머병 임상진단 보조 · 임상 완료(2017년 품목허가용 임상시험계획서 승인) · Clinical sensitivity and specificity evaluated at Seoul National University Bundang Hospital and Chung-Ang University Hospital
AI reads
MAA server logs · IP-verifiedSomeone asked an AI a question, and it fetched this page live to answer.
Collected for later use. Not a signal of interest.
- OpenAIOAI-SearchBot1
Measured since Aug 25, 2026 · 1 AI engines · last read Aug 25, 2026
User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS.
Companies approved for the same productsMedical Devices
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
KOSDAQ-listed point-of-care immunodiagnostics company supplying diagnostic cartridges and the ichroma/AFIAS instrument series.
GC Medical Science Corporation, KOSDAQ-listed since 2014, operates diagnostic reagent, blood glucose, and hemodialysis solution businesses.
KOSPI-listed in-vitro diagnostics company known for the STANDARD Q antigen/antibody test kits.
KOSDAQ-listed industrial biotech producing cephalosporin precursor enzyme CX and antibody-purification Protein A resin.
KOSDAQ-listed biotech company developing molecular diagnostics with proprietary C-Tag technology and the NeoPlex product line.
KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.
KOSDAQ-listed bioprocess and biomedical company supplying the CELBIC single-use cell culture system and the DxBIC automated analysis system.
NKGen Biotech Korea licenses out NK cell therapy patents to NKGen Biotech Inc. and provides immune diagnostic and healthcare products.
KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.
KOSDAQ-listed in-vitro diagnostics company selling PROTIA Allergy-Q allergy diagnostic products domestically and in 80+ countries.
Established in 2010, listed on KOSDAQ in 2020, QuantaMatrix develops dRAST and QDST antimicrobial susceptibility testing systems.
Develops SimplexTAS, a point-of-care clinical chemistry and immunoassay analyzer for IVD testing.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition